Equity Research, Broker Reports, and media content on Physiomics Plc

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Physiomics Plc
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Physiomics Plc

Company Profile

  • Personnel
  • Christophe Chassagnole, COO
  • Paul Harper, Chairman
  • James Simon Millen, CEO

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Physiomics Plc. We currently have 48 research reports from 1 professional analysts.

  • Open: 7.50p
  • Range Today: 7.33/7.72p
  • 52 Week: 1.30/17.2p
  • Daily Volume: 554.0k
  • Daily Liquidity: (0.57%)
  • # Shares: 97.3m
  • Market Cap: £7.40m
  • Latest PE (hist):
  • Div Yield:
Date Source Announcement
15Feb21 07:00 RNS ValiRx Agreement
18Dec20 07:00 RNS Holding(s) in Company
17Dec20 14:00 RNS Partnership with TRHC's DoseMeRx®
17Dec20 07:00 RNS Merck Contracts
14Dec20 07:00 RNS Approval of NIHR-funded PARTNER study
17Nov20 12:59 RNS Result of AGM
22Oct20 08:30 RNS Posting of Annual Report and AGM Notice
  • Frequency of research reports


  • Research reports on

    Physiomics Plc

  • Providers covering

    Physiomics Plc